Monthly revenue and year-on-year change for PEC (6446) and HeXun Biosciences (6986) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | PEC | YoY | HeXun Biosciences | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.84 billion | +102.0% | NT$10.6 million | -59.8% |
| Sep 2026 | NT$2.64 billion | +100.0% | NT$16.7 million | -22.7% |
| Aug 2026 | NT$2.62 billion | +105.4% | NT$21.4 million | +4.8% |
| Jul 2026 | NT$2.51 billion | +92.6% | NT$15.3 million | +5.8% |
| Jun 2026 | NT$2.33 billion | +94.9% | NT$30.4 million | +13.4% |
| May 2026 | NT$2.46 billion | +108.5% | NT$46.8 million | +10.1% |
| Apr 2026 | NT$2.06 billion | +68.3% | NT$16.7 million | -46.8% |
| Mar 2026 | NT$1.94 billion | +64.4% | NT$38.1 million | +80.8% |
| Feb 2026 | NT$1.6 billion | +56.7% | NT$19.1 million | +10.9% |
| Jan 2026 | NT$1.58 billion | +49.8% | NT$15.4 million | +23.1% |
| Dec 2025 | NT$1.92 billion | +69.9% | NT$33.8 million | +5.4% |
| Nov 2025 | NT$1.55 billion | +53.0% | NT$25 million | -7.3% |
| Oct 2025 | NT$1.4 billion | +53.6% | NT$26.5 million | +0.3% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16